Tag: COVID-19 therapeutic
SAB Biotherapeutics awarded $57.5 to manufacture its therapeutic candidate for COVID-19
Clinical stage biopharma company SAB Biotherapeutics has been awarded $57.5 million from BARDA and the US Department of Defence for the manufacturing of SAB-185,...
Featured Article
Sydney to spotlight the latest in manufacturing at AMW 2024
With the Australian Manufacturing Week (AMW) 2024 fast approaching, Sydney is set to become the epicentre of groundbreaking innovations in the advanced manufacturing sector.Â
